1 Characteristics of Streptococcus pseudopneumoniae isolated from purulent sputum samples

2 The NOW S. pneumoniae urinary antigen test positivity rate 6 weeks after pneumonia onset and among patients with COPD

3 Relationships between respiratory and airway resistances and activity-related dyspnea in patients with chronic obstructive pulmonary disease

4 Self-management plans in the primary care of patients with chronic obstructive pulmonary disease

5 Thirteen kinds of Chinese medicine injections for acute exacerbation of chronic obstructive pulmonary disease: Protocol for a systematic review and network meta-analysis.

6 Overview of pneumococcal serotypes and genotypes causing diseases in patients with chronic obstructive pulmonary disease in a Spanish hospital between 2013 and 2016

7 Current perspectives on treatment of hypertensive patients with chronic obstructive pulmonary disease

8 Overview of pneumococcal serotypes and genotypes causing diseases in patients with chronic obstructive pulmonary disease in a Spanish hospital between 2013 and 2016

9 Current perspectives on treatment of hypertensive patients with chronic obstructive pulmonary disease

10 Impact of chronic obstructive pulmonary disease on mortality: A large national cohort study.

11 Recommendations and practices for holistic chronic obstructive pulmonary disease (COPD) assessment and optimal referral patterns in emergency department presentations: a scoping review protocol.

12 Sleep disturbance in patients with mild-moderate chronic obstructive pulmonary disease.

13 Internet Health Behaviors of Patients with Chronic Obstructive Pulmonary Disease and Assessment of Two Disease Websites.

14 Role of Electrocardiographic Manifestations in Admission Decision in Patients with Chronic Obstructive Pulmonary Disease Exacerbation.

15 Progression of erectile function in men with chronic obstructive pulmonary disease: a cohort study.

16 Characterization of non-tuberculous mycobacterial pulmonary disease in Nanjing district of China.

17 T-regulatory cells subpopulation in bronchial asthma and heterogeneous phenotypes of chronic obstructive pulmonary disease

18 Chinese Herbal Medicine Versus Placebo for the Treatment Of Chronic Obstructive Pulmonary Disease: A Protocol of Systematic Review and Meta-analysis.

19 Safety and efficacy of acupuncture for the treatment of chronic obstructive pulmonary disease: A systematic review protocol.

20 PHYSIOTHERAPEUTIC APPROACHES AND THE EFFECTS ON INSPIRATORY MUSCLE FORCE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE IN THE PRE-OPERATIVE PREPARATION FOR ABDOMINAL SURGICAL PROCEDURES.

21 Pharmacological interventions for the treatment of anxiety and panic in chronic obstructive pulmonary disease

22 Changes in lower limb muscle function and muscle mass following exercise-based interventions in patients with chronic obstructive pulmonary disease: A review of the English-language literature

23 Association between Chronic Obstructive Pulmonary Disease and Dementia: Systematic Review and Meta-Analysis of Cohort Studies.

24 Air pollution exposures from multiple point sources and risk of incident chronic obstructive pulmonary disease (COPD) and asthma.

25 Pulmonary rehabilitation for people with chronic obstructive pulmonary disease: A protocol for an overview of Cochrane reviews.

26 Effect of marijuana smoking on pulmonary disease in HIV-infected and uninfected men: a longitudinal cohort study.

27 Prevalence of chronic obstructive pulmonary disease (COPD) and its associated factors among adults in Abeshge District, Ethiopia: a cross sectional study.

28 Real-world effectiveness of umeclidinium/vilanterol versus fluticasone propionate/salmeterol as initial maintenance therapy for chronic obstructive pulmonary disease (COPD): a retrospective cohort study.

29 Computer-Mediated Experiences of Patients with Chronic Obstructive Pulmonary Disease.

30 The Social and Economic Impact of Chronic Obstructive Pulmonary Disease on Maintenance-of-Way Railroad Workers.

31 Large-scale external validation and comparison of prognostic models: an application to chronic obstructive pulmonary disease

32 Unique synergistic antiviral effects of Shufeng Jiedu Capsule and oseltamivir in influenza A viral-induced acute exacerbation of chronic obstructive pulmonary disease.

33 Diabetes Mellitus and Chronic Obstructive Pulmonary Disease: An Overview.

34 Pathogenesis of chronic obstructive pulmonary disease (COPD) induced by cigarette smoke.

35 Chronic obstructive pulmonary disease and metabolic syndrome: Traveling with bad companies

36 Is oxidative stress associated with disease severity, pulmonary function and metabolic syndrome in chronic obstructive pulmonary disease?

37 TCM nonpharmacological interventions for chronic obstructive pulmonary disease (COPD): Protocol for a systematic review and network meta-analysis.

38 Obstructive pulmonary disease in patients with previous tuberculosis: Pathophysiology of a community-based cohort

39 Comorbidity: pulmonary tuberculosis and chronic obstructive pulmonary disease

40 Antimicrobial prescription in patients dying from chronic obstructive pulmonary disease.

41 Long-term air humidification therapy is cost-effective for patients with moderate or severe chronic obstructive pulmonary disease or bronchiectasis.

42 Acute care costs of patients admitted for management of chronic obstructive pulmonary disease exacerbations: contribution of disease severity, infection and chronic heart failure.

43 Serum Heat Shock Protein Levels and the Relationship of Heat Shock Proteins with Various Parameters in Chronic Obstructive Pulmonary Disease Patients.

44 Short Physical Performance Battery: What Does Each Sub-Test Measure in Patients with Chronic Obstructive Pulmonary Disease?

45 Intermittent Treatment with Azithromycin and Ethambutol for Noncavitary Mycobacterium avium Complex Pulmonary Disease

46 Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease

47 Response to letter to the Editor re ‘Pulmonary Rehabilitation Adapted Index of Self-Efficacy (PRAISE) tool predicts reduction in sedentary time following pulmonary rehabilitation in people with Chronic Obstructive Pulmonary Disease (COPD)’

48 Adherence to Therapy in Chronic Obstructive Pulmonary Disease: A Systematic Review.

49 Performance of the Binax NOW Streptococcus pneumoniae urinary antigen assay for diagnosis of pneumonia in children with underlying pulmonary diseases in the absence of acute pneumococcal infection

50 Role of Type2 Inflammatory Biomarkers in Chronic Obstructive Pulmonary Disease

51 Performance of the Binax NOW Streptococcus pneumoniae Urinary Antigen Assay for Diagnosis of Pneumonia in Children with Underlying Pulmonary Diseases in the Absence of Acute Pneumococcal Infection

52 β-blockers after acute myocardial infarction in patients with chronic obstructive pulmonary disease: a nationwide population-based observational study.

53 satisfaction and experience with a supervised home-based real-time videoconferencing telerehabilitation exercise program in people with chronic obstructive pulmonary disease (copd)

54 inhaled corticosteroids should not be prescribed to all chronic obstructive pulmonary disease patients

55 chronic obstructive pulmonary disease, diagnosis and treatment

56 health status measurement instruments in chronic obstructive pulmonary disease

57 the validity of diagnosing chronic obstructive pulmonary disease from a large administrative database

58 os fenótipos da doença pulmonar obstrutiva crónica e a sua relevância clínica chronic obstructive pulmonary disease phenotypes and their clinical relevance

59 myeloperoxidase promoter polymorphism −463g is associated with more severe clinical expression of cystic fibrosis pulmonary disease

60 cardiovascular and respiratory dysfunction in chronic obstructive pulmonary disease complicated by impaired peripheral oxygenation

61 procalcitonin: is it a predictor of noninvasive positive pressure ventilation necessity in acute chronic obstructive pulmonary disease exacerbation?

62 association of alpha-1 antitrypsin level and lung function in patients with chronic obstructive pulmonary disease

63 biomarkers in exhaled breath condensate and serum of chronic obstructive pulmonary disease and non-small-cell lung cancer

64 anemias in chronic obstructive pulmonary disease

65 paradoxical association between body mass index and in-hospital mortality in elderly patients with chronic obstructive pulmonary disease in japan

66 the association of chronic obstructive pulmonary disease, disability, engagement in social activities, and mortality among us adults aged 70 years or older, 1994–2006

67 study the association of chronic obstructive pulmonary disease with early endothelial dysfunction and its impact on cardiovascular system by estimating urinary albumin creatinine ratio

68 estudo de quatro anos de tiotrópio na doença pulmonar obstrutiva crónica (estudo uplift) a 4-year trial of tiotropium in chronic obstructive pulmonary disease (uplift trial)

69 compliance of patients with chronic obstructive pulmonary disease to a pulmonary rehabilitation program

70 the chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in copd

71 magnesium for acute exacerbation of chronic obstructive pulmonary disease: a systematic review of randomised trials

72 prevalence of chronic obstructive pulmonary disease among adult male cigarettes smokers: a community-based study in jordan

73 chronic obstructive pulmonary disease and sexual functioning among women in egypt

74 frequency and clinical relevance of human bocavirus infection in acute exacerbations of chronic obstructive pulmonary disease

75 improvement of airflow limitation by fluticasone propionate/salmeterol in chronic obstructive pulmonary disease: what is the specific marker?

76 The immediate effect of soft tissue manual therapy intervention on lung function in severe chronic obstructive pulmonary disease

77 roles for proteinases in the pathogenesis of chronic obstructive pulmonary disease

78 an overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease

79 balance impairment and systemic inflammation in chronic obstructive pulmonary disease

80 risks of on-pump coronary artery bypass grafting surgery in patients with chronic obstructive pulmonary disease due to sulfur mustard

81 the burden of illness related to chronic obstructive pulmonary disease exacerbations in québec, canada

82 endothelial dysfunction and morphofunctional properties of erythrocytes in non-alcoholic steathohepatitis combined with chronic obstructive pulmonary disease in patients with obesity

83 systemic inflammation in chronic pulmonary diseases – are we here now?

84 doença pulmonar obstrutiva crônica e fatores associados em são paulo, sp, 2008-2009 enfermedad pulmonar obstructiva crónica y factores asociados en sao paulo, sureste de brasil, 2008-2009 prevalence of chronic obstructive pulmonary disease and risk factors in são paulo, brazil, 2008-2009

85 treinamento de força para pacientes com doença pulmonar obstrutiva crônica strength training for patients with chronic obstructive pulmonary disease

86 chronic obstructive pulmonary disease and cardiac comorbidities: a cross-sectional study

87 why understanding the asthma chronic obstructive pulmonary disease overlap syndrome (acos) is important to the clinician

88 characteristics of stable chronic obstructive pulmonary disease patients in the pulmonology clinics of seven asian cities

89 guideline-based early detection of chronic obstructive pulmonary disease in eight danish municipalities: the top-kom study

90 efficacy and safety of eco-friendly inhalers: focus on combination ipratropium bromide and albuterol in chronic obstructive pulmonary disease

91 fine particulate air pollution and hospital admissions for chronic obstructive pulmonary disease: a case-crossover study in taipei

92 cognitive functions in nonhypoxemic chronic obstructive pulmonary disease (copd)

93 self-reported alcohol intake and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study

94 discharge medication counseling and its correlation with reducing readmissions for patients with chronic obstructive pulmonary disease exacerbations

95 improving the quality of life in patients with chronic obstructive pulmonary disease: focus on indacaterol

96 proinflammatory cytokine expression in patients with chronic obstructive pulmonary disease

97 association of egr-1 and autophagy-related gene polymorphism in men with chronic obstructive pulmonary disease

98 pulmonary rehabilitation in patients with chronic obstructive pulmonary disease

99 effect of a pulmonary rehabilitation program on the levels of anxiety and depression and on the quality of life of patients with chronic obstructive pulmonary disease

100 disease perception of moroccan immigrants with chronic obstructive pulmonary disease: a qualitative study

101 asthma-chronic obstructive pulmonary disease overlap (aco): an emerging entity in allergic respiratory diseases

Keyword Connections

Journals

Research Groups

Bibliographies